New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ARP;ZTS;OII;NCS;NILE;SSH;PTEN;NOV;HP;SFLY;OIS;NBR;EW;SPN;PDS From The Last 14 Days
Check below for free stories on ARP;ZTS;OII;NCS;NILE;SSH;PTEN;NOV;HP;SFLY;OIS;NBR;EW;SPN;PDS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
June 19, 2013
10:01 EDTSPNOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Coca-Cola (KO) initiated with an Outperform at Credit Suisse... Dr Pepper Snapple (DPS) initiated with a Neutral at Credit Suisse... Keryx (KERX) initiated with an Overweight at JPMorgan... Neurocrine Biosciences (NBIX) initiated with an Outperform at Oppenheimer... PepsiCo (PEP) initiated with a Neutral at Credit Suisse... Superior Energy (SPN) initiated with an Outperform at Cowen... Chambers Street Properties (CSG) initiated with a Neutral at Ladenburg... Synergy Resources (SYRG) initiated with an Outperform at Iberia... Callidus Software (CALD) initiated with a Buy at Lake Street... Teva (TEVA) initiated with a Buy at Maxim... Ubiquiti Networks (UBNT) initiated with an Outperform at JMP Securities... Vantiv (VNTV) initiated with an Overweight at Morgan Stanley... Visa (V) initiated with an Overweight at Morgan Stanley... MasterCard (MA) initiated with an Overweight at Morgan Stanley... Global Payments (GPN) initiated with an Underweight at Morgan Stanley... Green Dot (GDOT) initiated with an Underweight at Morgan Stanley... Total System (TSS) initiated with an Equal Weight at Morgan Stanley... MoneyGram (MGI) initiated with an Equal Weight at Morgan Stanley... Heartland Payment (HPY) initiated with an Equal Weight at Morgan Stanley... FleetCor (FLT) initiated with an Equal Weight at Morgan Stanley... Western Union (WU) initiated with an Equal Weight at Morgan Stanley... CorEnergy (CORR) initiated with an Outperform at Wells Fargo.
09:41 EDTNILEBlue Nile Q2 revenue estimates at risk, says ITG Research
Subscribe for More Information
07:58 EDTSPNAl Petrie Investor & Media Relations to hold a conference
Subscribe for More Information
07:51 EDTZTSEC fines Ranbaxy, others for blocking cheaper drugs, Economic Times reports
Subscribe for More Information
07:41 EDTZTSPfizer holders should consider Zoetis exchange, says BMO Capital
BMO Capital thinks Pfizer (PFE) investors should consider participating in the Zoetis (ZTS) exchange as they have the opportunity to own Zoetis at around $29.40-$29.70 per share, which is 15% below BMO's valuation of $34 per share. Further, BMO thinks there is strong support for Zoetis below $30, which the firm feels lowers downside risk. BMO recommends that Pfizer investors tender around 20% of their shares into the exchange, noting that with the offer likely being oversubscribed, not all tendered shares will be converted to Zoetis.
06:50 EDTSPNSuperior Energy initiated with an Outperform at Cowen
Subscribe for More Information
June 18, 2013
08:36 EDTZTSElan shares could be worh $19 in a buyout, says Jefferies
Jefferies raised its price target for shares of Elan (ELN) to $19 from $14, reflecting what it sees as the value of the company in a takeout scenario. The firm says Elan management suggested they would be open to sale in the $15-$20 per share range. Jefferies believes a high taxpaying suitor could pay the upper end of that range, and lists Allergan (AGN), Regeneron (REGN), Vertex (VRTX), Alexion (ALXN), Zoetis (ZTS), Mylan (MYL) and Perrigo (PRGO) as potential acquirers for Elan. Shares of Elan are up 13c to $13.62 in pre-market trading after Royalty Pharma announced that its buyout proposal for the company has expired.
07:38 EDTNBRTudor Pickering to host a conference
Subscribe for More Information
June 17, 2013
13:59 EDTNILEBlue Nile advances after analyst hikes rating to Outperform
Shares of online jewelry retailer Blue Nile (NILE) are climbing after research firm William Blair upgraded the stock in a note to investors earlier today. WHAT'S NEW: William Blair analyst Mark Miller upgraded Blue Nile to Outperform from Market Perform, as he believes that external conditions are becoming more favorable to the company, while its initiatives appear to be working. Specifically, the retailer should benefit from rising consumer confidence, increased access to consumer credit and stable diamond prices, Miller wrote. Blue Nile should also be boosted by new strategic marketing campaigns and its decision to offer more types of wedding bands, the analyst contended. Moreover, Miller believes that the company has been doing well this quarter, while its customer satisfaction levels have been improving, PRICE ACTION: In mid-afternoon trading, Blue Nile rose $1.70, or 4.6%, to $49.
10:10 EDTNILEOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:33 EDTNILEFollow-up: Blue Nile upgraded to Outperform at William Blair
Subscribe for More Information
09:13 EDTNILEBlue Nile upgraded to Outperform from Market Perform at William Blair
Subscribe for More Information
June 14, 2013
17:22 EDTZTSZoetis to be added to S&P 500; First Horizon deleted as of 6/21 close
09:57 EDTEWCourt ruling a minor negative for Edwards Lifesciences, says Leerink
Subscribe for More Information
09:45 EDTEWEdwards lost first of three cases against Medtronic, says Wells Fargo
Subscribe for More Information
07:53 EDTEWEdwards loses patent bid in Germany versus Medtronic, Bloomberg says
A German court ruled that Edwards Lifescience's (EW) patent does not cover Medtronic's (MDT) product, Bloomberg reports.
06:45 EDTZTSZoetis volatility elevated into Pfizer split-off
Subscribe for More Information
06:23 EDTZTSZoetis implied volatility at upper end of index mean range
Subscribe for More Information
June 13, 2013
16:19 EDTOISOil States announces new Permian Basin locations
Subscribe for More Information
June 11, 2013
07:31 EDTEWGoldman to host a conference
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use